pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)
Source abstract
Abstract
Improved treatment of acute myeloid leukemia (AML) could be possible by longer retention of anticancer drugs in the bloodstream. In this study, it was aimed to obtain improved treatment against AML by providing prolonged blood levels of doxorubicin and ensuring endosomal escape by the proton sponge effect. With this aim, pH-sensitive and chitosan-poly ethylene glycol (Cs-PEG) coated doxorubicin-loaded hollow mesoporous silica nanoparticles (C-HMSN-DN) were prepared. Nanoparticles (NPs) were characterized by dynamic light scattering (DLS), zeta potential, transmission electron microscopy (TEM), X-Ray diffraction (XRD), and nitrogen adsorption-desorption isotherms. High doxorubicin encapsulation efficacy was obtained as 90%. pH-sensitive formulations were showed higher cellular uptake and found more effective against human leukemia cell line (HL60) than non-pH sensitive formulations. In vivo studies showed that Cs-PEG coating prolonged blood circulation time tremendously in comparison to unmodified nanoparticles and free doxorubicin. The designed drug delivery system (DDS) can be more effective by endosomal escape to eliminate myeloid cells which are granular cells containing a great number of lysosomes. In conclusion, we present a drug delivery system that provides a prolonged blood circulation time due to Cs-PEG coating and effective drug delivery via pH-sensitive drug release and endosomal escape for AML treatment.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Abumanhal-Masarweh H, Koren L, Zinger A, Yaari Z, Krinsky N, Kaneti G, Dahan N, Lupu-Haber Y, Suss-Toby E, Weiss-Messer E, Schlesinger-Laufer M, Shainsky-Roitman J, Schroeder A (2019) Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin. J Control Release 296:1–1310.1016/j.jconrel.2019.01.004 ↗
2. Bagwe RP, Hilliard LR, Tan W (2006) Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 22:4357–436210.1021/la052797j ↗
3. Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D, Alkilany AM, Farokhzad OC, Mahmoudi M (2017) Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev 46:4218–424410.1039/C6CS00636A ↗
4. Cai D, Han C, Liu C, Ma X, Qian J, Zhou J, Li Y, Sun Y, Zhang C, Zhu W (2020) Chitosan-capped enzyme-responsive hollow mesoporous silica nanoplatforms for colon-specific drug delivery. Nanoscale Res Lett 15:12310.1186/s11671-020-03351-8 ↗
5. Chen Y, Chen H, Guo L, He Q, Chen F, Zhou J, Feng J, Shi J (2010) Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 4:529–53910.1021/nn901398j ↗
6. Chen Y, Yang W, Chang B, Hu H, Fang X, Sha X (2013) In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Eur J Pharm Biopharm 85:406–41210.1016/j.ejpb.2013.06.015 ↗
7. Daeihamed M, Haeri A, Dadashzadeh S (2015) A simple and sensitive HPLC method for fluorescence quantitation of doxorubicin in micro-volume plasma: applications to pharmacokinetic studies in rats, Iran. J Pharm Res 14:33–4210.18579/jpcrkc/2015/14/2/79075 ↗
8. Daryasari MP, Akhgar MR, Mamashli F, Bigdeli B, Khoobi M (2016) Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery. RSC Adv 6:105578–10558810.1039/C6RA23182A ↗
9. Fang X, Chen C, Liu Z, Liu P, Zheng N (2011) A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale 3:1632–163910.1039/c0nr00893a ↗
10. Fang X, Zhao X, Fang W, Chen C, Zheng N (2013) Self-templating synthesis of hollow mesoporous silica and their applications in catalysis and drug delivery. Nanoscale 5:2205–221810.1039/c3nr34006f ↗
11. Feng W, Nie W, He C, Zhou X, Chen L, Qiu K, Wang W, Yin Z (2014) Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. ACS Appl Mater Interfaces 6:8447–846010.1021/am501337s ↗
12. Fleischer CC, Payne CK (2014) Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res 47:2651–265910.1021/ar500190q ↗
13. Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y (2011) Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 5:9788–979810.1021/nn2033105 ↗
14. García-Fernández A, Aznar E, Martínez-Máñez R, Sancenón F (2020) New advances in in vivo applications of gated mesoporous silica as drug delivery nanocarriers. Small 16:190224210.1002/smll.201902242 ↗
15. Glorani G, Marin R, Canton P, Pinto M, Conti G, Fracasso G, Riello P (2017) Pegylated silica nanoparticles: cytotoxicity and macrophage uptake. J Nanopart Res 19:29410.1007/s11051-017-3964-x ↗
16. Gunawan C, Lim M, Marquis CP, Amal R (2014) Nanoparticle-protein corona complexes govern the biological fates and functions of nanoparticles. J Mater Chem B 2:2060–208310.1039/c3tb21526a ↗
17. Han N, Zhao Q, Wan L, Wang Y, Gao Y, Wang P, Wang Z, Zhang J, Jiang T, Wang S (2015) Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. ACS Appl Mater Interfaces 7:3342–335110.1021/am5082793 ↗
18. Herd H, Daum N, Jones AT, Huwer H, Ghandehari H, Lehr CM (2013) Nanoparticle geometry and surface orientation influence mode of cellular uptake. ACS Nano 7:1961–197310.1021/nn304439f ↗
19. Inocêncio S, Cordeiro T, Matos I, Danède F, Sotomayor JC, Fonseca IM, Correia NT, Corvo MC, Dionísio M (2021) Ibuprofen incorporated into unmodified and modified mesoporous silica: from matrix synthesis to drug release. Microporous Mesoporous Mater 310:11054110.1016/j.micromeso.2020.110541 ↗
20. Kaasalainen M, Aseyev V, von Haartman E, Karaman DŞ, Mäkilä E, Tenhu H, Rosenholm J, Salonen J (2017) Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering. Nanoscale Res Lett 12:7410.1186/s11671-017-1853-y ↗
21. Kanwal U, Irfan Bukhari N, Ovais M, Abass N, Hussain K, Raza A (2018) Advances in nano-delivery systems for doxorubicin: an updated insight. J Drug Target 26:296–31010.1080/1061186X.2017.1380655 ↗
22. Ke C-J, Su T-Y, Chen H-L, Liu H-L, Chiang W-L, Chu P-C, Xia Y, Sung H-W (2011) Smart multifunctional hollow microspheres for the quick release of drugs in intracellular lysosomal compartments. Angew Chem Int Ed 50:8086–808910.1002/anie.201102852 ↗
23. Krischke M, Hempel G, Völler S, André N, D’Incalci M, Bisogno G, Köpcke W, Borowski M, Herold R, Boddy AV, Boos J (2016) Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial. Cancer Chemother Pharmacol 78:1175–118410.1007/s00280-016-3174-8 ↗
24. Llopis-Lorente A, Lozano-Torres B, Bernardos A, Martínez-Máñez R, Sancenón F (2017) Mesoporous silica materials for controlled delivery based on enzymes. J Mater Chem B 5:3069–308310.1039/C7TB00348J ↗
25. Mekaru H, Lu J, Tamanoi F (2015) Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy. Adv Drug Deliv Rev 95:40–4910.1016/j.addr.2015.09.009 ↗
26. Pisani C, Gaillard JC, Odorico M, Nyalosaso JL, Charnay C, Guari Y, Chopineau J, Devoisselle JM, Armengaud J, Prat O (2017) The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome. Nanoscale 9:1840–185110.1039/C6NR04765C ↗
27. Popat A, Liu J, Lu GQ, Qiao SZ (2012) A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles. J Mater Chem 22:11173–1117810.1039/c2jm30501a ↗
28. Radu DR, Lai C-Y, Jeftinija K, Rowe EW, Jeftinija S, Lin VSY (2004) A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc 126:13216–1321710.1021/ja046275m ↗
29. Rawal M (2018) CHAPTER 2 Materials and chemistry of stimuli-responsive drug delivery systems, stimuli-responsive drug delivery systems. R Soc Chem 33–5010.1039/9781788013536-00033 ↗
30. Robbins SL, Kumar V (2008) Robbins temel patoloji: (basic pathology), Nobel Tıp Kitabevi
31. Roca M, Haes AJ (2008) Silica−void−gold nanoparticles: temporally stable surface-enhanced Raman scattering substrates. J Am Chem Soc 130:14273–1427910.1021/ja8059039 ↗
32. Stewart BW, Wild C (2014) World cancer report 2014. International Agency for Research on Cancer, WHO Press, Lyon
33. Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2016) PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28–5110.1016/j.addr.2015.09.012 ↗
34. Sun Y-L, Yang B-J, Zhang SX-A, Yang Y-W (2012) Cucurbit [7] uril pseudorotaxane-based photoresponsive supramolecular nanovalve. Chem Eur J 18:9212–921610.1002/chem.201201083 ↗
35. Szegedi A, Popova M, Goshev I, Klébert S, Mihály J (2012) Controlled drug release on amine functionalized spherical MCM-41. J Solid State Chem 194:257–26310.1016/j.jssc.2012.05.030 ↗
36. Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65:157–17010.1111/j.2042-7158.2012.01567.x ↗
37. Teng Z, Su X, Zheng Y, Sun J, Chen G, Tian C, Wang J, Li H, Zhao Y, Lu G (2013) Mesoporous silica hollow spheres with ordered radial mesochannels by a spontaneous self-transformation approach. Chem Mater 98–10510.1021/cm303338v ↗
38. Torchilin VP (2018) CHAPTER 1 Fundamentals of stimuli-responsive drug and gene delivery systems, stimuli-responsive drug delivery systems. R Soc Chem 1–3210.1039/9781788013536-00001 ↗
39. Tuoriniemi J, Johnsson A-CJH, Holmberg JP, Gustafsson S, Gallego-Urrea JA, Olsson E, Pettersson JBC, Hassellöv M (2014) Intermethod comparison of the particle size distributions of colloidal silica nanoparticles. Sci Technol Adv Mater 15:03500910.1088/1468-6996/15/3/035009 ↗
40. Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) Endosomal escape pathways for delivery of biologicals. J Control Release 151:220–22810.1016/j.jconrel.2010.11.004 ↗
41. Wang Z, Zhang X, Huang G, Gao J (2018) CHAPTER 3 pH-responsive drug delivery systems, stimuli-responsive drug delivery systems. R Soc Chem 51–8210.1039/9781788013536-00051 ↗
42. Xiong L, Du X, Kleitz F, Qiao SZ (2015) Cancer-cell-specific nuclear-targeted drug delivery by dual-ligand-modified mesoporous silica nanoparticles. Small 11:5919–592610.1002/smll.201501056 ↗
43. Xu P, Zuo H, Chen B, Wang R, Ahmed A, Hu Y, Ouyang J (2017) Doxorubicin-loaded platelets as a smart drug delivery system: an improved therapy for lymphoma. Sci Rep 7:4263210.1038/srep42632 ↗
44. Yoo S, Lee J, Kim JM, Seong CY, Seong KD, Piao Y (2016) Well-dispersed sulfur wrapped in reduced graphene oxide nanoscroll as cathode material for lithium-sulfur battery. J Electroanal Chem 780:19–2510.1016/j.jelechem.2016.08.040 ↗
45. Zhao Q, Wang C, Liu Y, Wang J, Gao Y, Zhang X, Jiang T, Wang S (2014) PEGylated mesoporous silica as a redox-responsive drug delivery system for loading thiol-containing drugs. Int J Pharm 477:613–62210.1016/j.ijpharm.2014.10.056 ↗
46. Zhu Y, Fang Y, Borchardt L, Kaskel S (2011) PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Microporous Mesoporous Mater 141:199–20610.1016/j.micromeso.2010.11.013 ↗